All 3 FDA authorized COVID-19 vaccines in use here in USA employ a prefusion “locked” Spike, a beautiful innovation developed by @McLellan_Lab@BarneyGrahamMD@KizzyPhD & others..
which results in superior antibody responses because it trains the immune response on the right target 🎯
This is important because the Spike (like all viral membrane fusion proteins has 2 forms: a prefusion form, and a postfusion form..
The prefusion form is the one you want antibodies against. The postfusion form is what the Spike looks like after it has already done its deed..
Which is to deliver the virus’ RNA genome into your cells..
AstraZeneca Oxford & Gamaleya Sputnik V vaccines do not use this strategy of locking the spike in the prefusion conformation.
For this reason, those native spike shots are less likely to work well against variants—
lower titers of antibodies and fewer B-cell clones developed against the correct target means less margin for error when the virus mutates and comes up with new Spike variants..
Here is @McLellan_Lab’s CLASSIC 2017 paper that laid the groundwork for locking the SARS-CoV-2 Spike. He first pulled it off with the Spike of MERS, a related & also very dangerous coronavirus pnas.org/content/114/35…
I should also acknowledge @goodwish916 who played a very big role in a lot this work, too!
And also worth noting that before they got around to coronaviruses like MERS and SARS2, @McLellan_Lab@BarneyGrahamMD locked the respiratory syncytial virus fusion protein, “F”.. which is from an entirely different virus family (paramyxoviruses) science.sciencemag.org/content/340/61…
..back to SARS-CoV-2, here’s Jason’s lab’s latest locked 🔒 Spike, “HexaPro,”which has 6 proline substitutions instead of just 2. It is likely an even better immunogen. science.sciencemag.org/content/369/65…
Peter Palese & @florian_krammer are already testing HexaPro using a Newcastle Disease virus (NDV) vector in human volunteers!
Someone asked me today, "In two sentences or less could you answer the question “Why is Genome Sequencing important?”. . . I failed at the 2 sentences part, but...🧵
Sequencing the entire genomes of viruses, bacteria, and fungi that cause disease is called “genomic surveillance”
The sequencing technologies have gotten less and less expensive and at the same time far more powerful than ever before
"Double Mutant" Report! Congrats & Thank you to scientists at India's CSIR-National Environmental Engineering Research Institute & Centre for Cellular & Molecular Biology/ INSACOG for sharing via @GISAID the🧬data for 36 new Spike L452R, E484Q from Maharashtra and West Bengal.
Many samples were from asymptomatic patients, and are all lineage B.1, and the S mutations on many / most of them are.. (36 of the 38 are also P681R, which prob increases processing of the polybasic site at the S1/S2 boundary)
D614G
E154K
E484Q
L452R
P681R
+/- T95I
+/- H1101D
Probably best not to call them "double mutant" as the news reports have.. but maybe sexta-mutant S 😆?
Global and regional implications for public health, and for equal access to scientific research research 🔬 opportunities & education
There is a looming federal + private budgeting quandary over what the future looks like for 1.) who gets funded to conduct viral genomic surveillance and 2.) who gets to hold and analyze the data?
Essentially, you'd like a bailout, right? You're no different than an oil company asking for free access to public mineral rights. Pathogen sequences are valuable to human and veterinary health.. those who generate them need incentives.. either financial or authorship, etc.
Instead of asking us to give our data away for free, why don't you instead try competing for NIH SBIR or DARPA funding?
GISAID and many other organizations who access GISAID data already publish info necessary to do any of the things he is speaking of wrt design of diagnostics.
David entirely ignores or is somehow unaware of the fact that a HUGE amount of sequencing would not even be getting done if not for the incentives that GISAID DUA provides to stimulate sequencing and open sharing!
A request to people who are sane: do you like to work for free and have others publish based on your data without citing you, then follow this guys advice 👇🏼👇🏼👇🏼